SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-4.91%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$497M
AUM Growth
+$497M
(+66%)
Cap. Flow
-$12.7M
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
59.18%
Holding
270
New
59
Increased
53
Reduced
43
Closed
46
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$22.4M |
| 2 |
Amgen
AMGN
|
$21.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$14.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
$9.88M |
| 5 |
Biogen
BIIB
|
$9.65M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$33.1M |
| 2 |
Plus Therapeutics
PSTV
|
$19.2M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$9.8M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
$7.26M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$6.48M |
Sector Composition
| 1 | Healthcare | 48.01% |
| 2 | Consumer Staples | 0.23% |
| 3 | Technology | 0.19% |
| 4 | Industrials | 0.18% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Opko Health
OPK
$1.1B
| $1.16M | 0.06% |
112,011
+14,200
| +15% | +$148K |
|
|
RIBT
77
DELISTED
RiceBran Technologies
RIBT
| $1.14M | 0.06% |
1,017,458
+84,017
| +9% | +$94.1K |
|
78
Standard BioTools
LAB
$493M
| $1.13M | 0.06% |
139,506
-124,690
| -47% | -$1.01M |
|
|
SGYP
79
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.08M | 0.05% |
+392,273
| New | +$1.08M |
|
80
Champions Oncology
CSBR
$95.8M
| $1.08M | 0.05% |
295,328
+3,733
| +1% | +$13.6K |
|
|
XTLB
81
XTL Biopharmaceuticals
XTLB
$10.4M
| $1.07M | 0.05% |
1,040,194
-71,768
| -6% | -$74K |
|
82
Savara
SVRA
$591M
| $1.06M | 0.05% |
+3,877,356
| New | +$1.06M |
|
|
RGLS
83
DELISTED
Regulus Therapeutics
RGLS
| $970K | 0.05% |
140,000
-70,000
| -33% | -$485K |
|
|
CASC
84
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $939K | 0.05% |
+739,004
| New | +$939K |
|
|
WINT
85
DELISTED
Windtree Therapeutics Inc
WINT
| $934K | 0.05% |
566,352
-6,773,196
| -92% | +$69.4K |
|
86
Tonix Pharmaceuticals
TNXP
$243M
| $928K | 0.05% |
385,248
+229,691
| +148% | -$1.19M |
|
87
Quest Resource Holding
QRHC
$35.6M
| $895K | 0.04% |
2,131,914
-303,123
| -12% | -$127K |
|
88
Rocket Pharmaceuticals
RCKT
$358M
| $862K | 0.04% |
116,454
+28,802
| +33% | +$213K |
|
89
Abeona Therapeutics
ABEO
$356M
| $855K | 0.04% |
334,108
+34,108
| +11% | +$87.3K |
|
|
RXDX
90
DELISTED
Ignyta, Inc.
RXDX
| $846K | 0.04% |
125,000
+70,901
| +131% | +$480K |
|
|
TMBR
91
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $845K | 0.04% |
+775,000
| New | +$845K |
|
|
ARLZ
92
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $839K | 0.04% |
+236,364
| New | +$839K |
|
93
TherapeuticsMD
TXMD
$12.7M
| $835K | 0.04% |
+130,400
| New | +$835K |
|
|
TBRA
94
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $818K | 0.04% |
100,000
-777,342
| -89% | -$6.36M |
|
|
ACHN
95
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $816K | 0.04% |
+105,648
| New | +$816K |
|
96
Sangamo Therapeutics
SGMO
$161M
| $814K | 0.04% |
134,500
+3,400
| +3% | +$20.6K |
|
|
CYNA
97
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $792K | 0.04% |
66,522
+7,912
| +13% | +$94.2K |
|
98
EyePoint Pharmaceuticals
EYPT
$827M
| $787K | 0.04% |
+293,585
| New | +$787K |
|
|
WGBS
99
DELISTED
WaferGen Bio-systems, Inc.
WGBS
| $765K | 0.04% |
1,195,470
-185,604
| -13% | -$119K |
|
100
Arcturus Therapeutics
ARCT
$467M
| $761K | 0.04% |
200,868
+33,368
| +20% | +$126K |
|